The Personalized Psychiatry Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Personalized Psychiatry Market?
The global market for personalized psychiatry has seen significant expansion in recent years. The market size increased from $5.69 billion in 2024 to $6.53 billion in 2025, representing a compound annual growth rate (CAGR) of 14.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Personalized Psychiatry Industry?
The market size for personalized psychiatry is projected to reach $11.24 billion in 2029, increasing at a compound annual growth rate (CAGR) of 14.6%.
Download Your Free Sample of the 2025 Personalized Psychiatry Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Personalized Psychiatry Market?
The key drivers in the personalized psychiatry market are:
• Expansion and increasing use of digital therapeutics
• Rising requirement for remote patient monitoring in mental health
• Growth in demand for mental health solutions due to consequences of COVID-19
• Increased investments by government and private sectors in mental health sector
Global Market Segmentation: Identifying Major Personalized Psychiatry Industry Segments
The personalized psychiatry market covered in this report is segmented –
1) By Type: Products, Services, Software
2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics
3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)
4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings
Pre-order the 2025 Personalized Psychiatry Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Personalized Psychiatry Market?
The key trends in the personalized psychiatry market are:
• Enhanced use of artificial intelligence in diagnosing mental health conditions is a major trend.
• Growing popularity of telepsychiatry and online consultations is shaping the market.
• Integration of blockchain technology for mental health data security is emerging.
• Rising use of virtual reality for therapeutic treatments and wearable devices for mental health monitoring are significant trends.
Who Are the Top Competitors & Leading Players in the Personalized Psychiatry Market?
Major players in the personalized psychiatry market are:
• Johnson & Johnson
• AbbVie Inc.
• Bristol-Myers Squibb
• Medtronic Plc
• Takeda Pharmaceutical Company
• Boehringer Ingelheim
• Otsuka Pharmaceutical Co. Ltd.
• H. Lundbeck A/S
• Neurocrine Biosciences
• Spring Health
• Neumora Therapeutics Inc.
• Atai Life Sciences
• Valera Health
• Compass Pathways
• Genomind
• Woebot Health
• BrightQuest Treatment Centers
• Meru Health
• Alto Neuroscience
• Arcara Personalized Psychiatry
• GreyBird Ventures
• Mind Sync Therapeutics
• Starling Minds
• HMNC Holding GmbH.
Regional Dominance: Which Area Leads the Global Personalized Psychiatry Market?
North America was the largest region in the personalized psychiatry market in 2024
